William Blair & Company’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41K | Sell |
10,000
-500
| -5% | -$271 | ﹤0.01% | 1760 |
|
|
2025
Q1 | $6.89K | Hold |
10,500
| – | – | ﹤0.01% | 1737 |
|
|
2024
Q4 | $10.7K | Sell |
10,500
-40,000
| -79% | -$40.8K | ﹤0.01% | 1732 |
|
|
2024
Q3 | $43.7K | Sell |
50,500
-9,402
| -16% | -$8.14K | ﹤0.01% | 1647 |
|
|
2024
Q2 | $21.5K | Sell |
59,902
-65,000
| -52% | -$23.3K | ﹤0.01% | 1682 |
|
|
2024
Q1 | $83.7K | Hold |
124,902
| – | – | ﹤0.01% | 1534 |
|
|
2023
Q4 | $67.9K | Sell |
124,902
-150,000
| -55% | -$81.5K | ﹤0.01% | 1556 |
|
|
2023
Q3 | $165K | Sell |
274,902
-20,000
| -7% | -$12K | ﹤0.01% | 1427 |
|
|
2023
Q2 | $383K | Hold |
294,902
| – | – | ﹤0.01% | 1152 |
|
|
2023
Q1 | $519K | Hold |
294,902
| – | – | ﹤0.01% | 1034 |
|
|
2022
Q4 | $926K | Sell |
294,902
-50,000
| -14% | -$157K | ﹤0.01% | 846 |
|
|
2022
Q3 | $1.69M | Hold |
344,902
| – | – | 0.01% | 659 |
|
|
2022
Q2 | $1.43M | Hold |
344,902
| – | – | 0.01% | 730 |
|
|
2022
Q1 | $2M | Hold |
344,902
| – | – | 0.01% | 696 |
|
|
2021
Q4 | $2.59M | Buy |
+344,902
| New | +$2.59M | 0.01% | 649 |
|
|
2017
Q3 | – | Sell |
-12,100
| Closed | -$106K | – | 1395 |
|
|
2017
Q2 | $106K | Buy |
12,100
+500
| +4% | +$4.38K | ﹤0.01% | 1367 |
|
|
2017
Q1 | $60K | Hold |
11,600
| – | – | ﹤0.01% | 1261 |
|
|
2016
Q4 | $35K | Buy |
11,600
+300
| +3% | +$905 | ﹤0.01% | 1214 |
|
|
2016
Q3 | $52K | Buy |
11,300
+900
| +9% | +$4.14K | ﹤0.01% | 1227 |
|
|
2016
Q2 | $60K | Sell |
10,400
-5,500
| -35% | -$31.7K | ﹤0.01% | 1193 |
|
|
2016
Q1 | $96K | Sell |
15,900
-5,500
| -26% | -$33.2K | ﹤0.01% | 1124 |
|
|
2015
Q4 | $195K | Buy |
+21,400
| New | +$195K | ﹤0.01% | 1086 |
|